Literature DB >> 27408386

Cholestasis in a Patient of Multiple Myeloma: A Rare Occurrence of Bortezomib Induced Liver Injury.

Ankur Jain1, Pankaj Malhotra1, Vikas Suri1, Subhash Varma1, Ashim Das2, Suvradeep Mitra2.   

Abstract

Entities:  

Year:  2016        PMID： 27408386      PMCID： PMC4925560          DOI： 10.1007/s12288-016-0665-z

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  7 in total

1.  Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma.

Authors:  A Trojan; E Chasse; B Gay; G Pichert; C Taverna
Journal:  Ann Oncol       Date:  2003-03       Impact factor: 32.976

2.  Evolution of hepatosplenic plasmacytoma in a patient with multiple myeloma receiving chemotherapy.

Authors:  Pankaj Malhotra; Pradeep Bhat; Sushil Mahi; Sandeep Chauhan; Arvind Rajwanshi; Subhash Varma
Journal:  Am J Hematol       Date:  2005-01       Impact factor: 10.047

3.  ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury.

Authors:  Naga P Chalasani; Paul H Hayashi; Herbert L Bonkovsky; Victor J Navarro; William M Lee; Robert J Fontana
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

4.  Bortezomib-induced severe hepatitis in multiple myeloma: a case report.

Authors:  Laura Rosiñol; Silvia Montoto; Maria Teresa Cibeira; Joan Bladé
Journal:  Arch Intern Med       Date:  2005-02-28

5.  Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?

Authors:  Raj Vuppalanchi; Suthat Liangpunsakul; Naga Chalasani
Journal:  Am J Gastroenterol       Date:  2007-03       Impact factor: 10.864

6.  Hepatic failure caused by plasma cell infiltration in multiple myeloma.

Authors:  Fadi-E Rahhal; Robert-R Schade; Asha Nayak; Teresa A Coleman
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

7.  A Case of Drug-Induced Hepatitis due to Bortezomib in Multiple Myeloma.

Authors:  Youngwoon Kim; Ka Young Kim; Su Hyun Lee; Yoon Yung Chung; Seung-Ah Yahng; Sung-Eun Lee; Gyeongsin Park; Chang-Ki Min
Journal:  Immune Netw       Date:  2012-06-30       Impact factor: 6.303
  7 in total
  1 in total

1.  Proteasome dysfunction under compromised redox metabolism dictates liver injury in NASH through ASK1/PPARγ binodal complementary modules.

Authors:  Debajyoti Das; Avishek Paul; Abhishake Lahiri; Moumita Adak; Sujay K Maity; Ankita Sarkar; Sandip Paul; Partha Chakrabarti
Journal:  Redox Biol       Date:  2021-06-11       Impact factor: 11.799
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.